WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 182
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 202

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 283  282  280  279  278  267  259  249 
Births
Surviving infants
Pop. less than 5 years 18  18  18  18  18  18  20  21 
Pop. less than 15 years 54  54  54  55  55  59  62  73 
Female 15-49 years 70  71  71  71  71  71  73  63 

Number of reported case

(Click for retrospective incidence data for Barbados)
Diphtheria
Japanese encephalitis
Measles 51  27 
Mumps
Pertussis
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 13 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Barbados)
Vaccine year result method % card seen                                                
BCG          89  81  92  95 
DTP1          93  85  93 
DTP3          87  91  86  93  85  93  91  60 
HepB_BD         
HepB3          87  91  86  93  85 
Hib3          87  91  86  93  85 
JapEnc         
MCV          90  93  85  94  94  94  87  41 
MCV2          90  94  96  97  97 
PCV1          75 
PCV3         
Pol3          88  91  90  93  85  86  90  99 
Rota1         
Rota_last         
Rubella1          90  93  85  94  94 
TT2plus          20 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Barbados)
DTP1 93  93  93  93  85  93  97  82 
DTP3 87  91  86  93  85  93  91  60 
HepB3 88  91  86  93  85 
Hib3 88  91  86  93  85 
MCV 90  93  85  94  94  94  87  41 
PCV3 75  75  75  75 
Pol3 88  91  90  93  85  86  90  99 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 5 years; Yes
DT 5-7 years;
DTwP 18 months; 4.5 years; Yes
DTwPHibHep 2, 4, 6 months; Yes
HepB Yes adults
IPV 2, 4, 6, 18 months; 4.5, 10-11 years; Yes children of HIV mothers
Influenza No at risk persons and HCW
MMR 1, 3-5 years; Yes
OPV 2, 4, 6, 18 months; 4.5, 10-11 years; Yes
Pneumo_conj 2, 4, 6 months; Yes
Td 10-11 years; Yes
Varicella >=18 years; Yes
YF Yes Travelers

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR No  Yes  No  No  No  No  Yes 
What years does the MYP cover? number             2003-2008 
Nº of districts with microplans that include activities to raise immunization coverage number    

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number
Nº districts with DTP3 coverage >=80% number      
% of districts with DTP3 coverage >=80% From 0 to 100%     100  100   
Nº districts with measles (MCV1) coverage >=95% number        
% of districts with MCV1 coverage >=95% From 0 to 100%        

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR   Yes      Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND   Yes           

Finance

Percentage of routine vaccines funded by Government From 0 to 100%   98  100  100    NA  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.